EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Geographic atrophy – Signs, symptoms, and quality of life

Marie Krogh Nielsen iD, Jenni Martinez Villarruel Hinnerskov, Torben Lykke Sørensen iD

Acta Ophthalmologica · 2023-12 · 101 (8) · 896-902

DOI: 10.1111/aos.15794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Ophthalmologica, online erschienen am 07.11.2023. Verfasst von Marie Krogh Nielsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Quality of Life, Geographic Atrophy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Geographic atrophy (GA) is a prevalent cause of vision loss among elderly and is associated with a significant loss of function. We reviewed the current literature to assess the effect of GA on patients' daily lives and well‐being. We record and organize the signs, symptoms, and impacts that are important in life with GA. Further, we examined the impact of GA on vision‐related quality of life. The main complaint among patients was difficulties regarding daily tasks, especially reading and other near activities. However, a large proportion of patients also reported fear, frustration, and anxiety as salient symptoms with large impact. Many patients do not have adequate information about their condition as well as the prognosis. The most commonly used measure of patient‐reported outcome measure (PROM) is the National Eye Institute Visual Function Questionnaire (VFQ), that reflects the severity of impact on 12 subscales, from where near activities, general vision, mental health, and role difficulties had the lowest scores. Longitudinal studies of GA and the impact of low‐vision rehabilitation efforts on health‐related quality of life are sparse but suggest a significant improvement on several items. PROM is included in clinical trials, and so far, no drug has shown to improve the functional outcome in terms of PROM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeGeographic AtrophyHumansAgedSickness Impact ProfileVisual AcuityVision, OcularSurveys and Questionnaires

Stichwörter der Autor:innen

age-related macular degenerationgeographic atrophypatient-reported outcome measuresquality of lifesymptoms

Autor:innen und Institutionen

  • Clinical Eye Research Division, Department of Ophthalmology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Marie Krogh Nielsen, Torben Lykke Sørensen

Zitieren

APA

Krogh Nielsen, M., Hinnerskov, J. M. V., & Sørensen, T. L. (2023). Geographic atrophy – Signs, symptoms, and quality of life. Acta Ophthalmologica, 101(8), 896-902. https://doi.org/10.1111/aos.15794

Vancouver

Krogh Nielsen M, Hinnerskov JMV, Sørensen TL. Geographic atrophy – Signs, symptoms, and quality of life. Acta Ophthalmologica. 2023;101(8):896-902. doi:10.1111/aos.15794

BibTeX
@article{KroghNielsen2023,
  author = {Krogh Nielsen, Marie and Hinnerskov, Jenni Martinez Villarruel and Sørensen, Torben Lykke},
  title = {Geographic atrophy – Signs, symptoms, and quality of life},
  journal = {Acta Ophthalmologica},
  year = {2023},
  volume = {101},
  number = {8},
  pages = {896--902},
  doi = {10.1111/aos.15794}
}
Kostenlos starten →